Jul
27
29
DHA Public Health Launches MilTICK SURE Path: Surveillance for Understudied, Rare Emerging Pathogens
The MilTICK program is expanding its disease surveillance to include deadly emerging pathogens. MilTICK SURE Path is a critical tool for defense public health entomology and public health officials in tracking emerging disease threats.
This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.
2/27/2008
An authorization from the FDA under section 564 of Reference (d) with respect to an unapproved product that allows, based on a declaration of emergency by the Secretary of Health and Human Services, the product to be introduced into interstate commerce for use or for the intended use, subject to terms and conditions established by the FDA. An EUA for an unapproved product exempts the product, within the terms of the EUA, from requirements applicable to investigational new drug.
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.